Evaluation and management of skeletal disease in cancer care
Recently, there have been considerable advancements in cancer therapies thereby prolonging the life of cancer survivors. However, these recent advancements present new challenges in the management of bone disease in cancer survivors. Bone acts as a fertile soil for cancer seeding and bone health is often compromised because of increased inflammatory cytokines in cancer, direct cancer metastasis and toxic effects of anti-cancer therapies. This effect is more pronounced in elderly population who already have compromised bone mineral density leading to increased skeletal related events and bone pain.
Source: Critical Reviews in Oncology Hematology - Category: Cancer & Oncology Authors: Anuhya Kommalapati, Mary Angelynne Esquivel, Ricardo Correa, Sri Harsha Tella Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Hematology | Pain | Pain Management | Toxicology